JP Morgan Reiterates Overweight Rating on Lexeo Therapeutics, Inc. Common Stock (LXEO)
Rating Change JP Morgan analysts reiterated a Overweight rating on Lexeo Therapeutics, Inc. Common Stock (NASDAQ:LXEO) on June 25, 2026. Market Context Lexeo Therapeutics, Inc.
Read more
